Source: Annual Congress 2010 - Practical Workshop: "Treatment of non-sleepy OSA patients"



Rating:

Share or cite this content

Citations should be made in the following way:
J. Meurice (Poitiers, France). Treatment of non-sleepy OSA patients - what are the alternatives ?. Annual Congress 2010 - Practical Workshop: "Treatment of non-sleepy OSA patients"

Member's Comments

No comment yet.

Related content which might interest you: Mild OSAS: Is CPAP therapy actually required for these patients? Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications Year: 2016 Con: should asymptomatic patients with moderate-to-severe ?OSA be treated? Source: Breathe, 15 (1) 11; 10.1183/20734735.0347-2018 Year: 2019 Differences between patients with overlap syndrome (COPD + OSAS) and patients with OSAS Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015 Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Nocturnal desaturation in COPD patients; is OSA screening the answer? Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Treatment of concomitant obstructive sleep apnea/hypopnea syndrome in patients with persistent poorly controlled bronchial asthma - Real opportunity to improve asthma control Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients? Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 Pro: should asymptomatic patients with moderate-to-severe OSA be treated? Source: Breathe, 15 (1) 7; 10.1183/20734735.0340-2018 Year: 2019 Positional therapy for obstructive sleep apnea: do your patients use it at home? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Auto-CPAP for treatment of OSAS in severe obese patients Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 When to treat elderly OSA patients Source: ERS Conference Year: 2015 Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 Personalised approach to treatment of children with obstructive sleep apnoea: what is the evidence? Source: Sleep and Breathing Conference 2021 Year: 2021 Life-sustaining treatment preferences of patients with severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 Are patients satisfied with a group approach to sleep studies for obstructive sleep apnoea? Source: Annual Congress 2007 - Quality, sleep and exercise - the ingredients for a perfect life! Year: 2007